Cargando…
Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway
Dexmedetomidine (Dex) was reported to reduce oxidative stress and protect against myocardial Ischemia/Reperfusion (I/R) injury. However, the molecular mechanism involved in its antioxidant property is not fully elucidated. The present study was aimed at investigating whether the Trx1/Akt pathway par...
Autores principales: | Wu, Zhi-lin, Davis, Jacques Robert Jeppe, Zhu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710428/ https://www.ncbi.nlm.nih.gov/pubmed/33299886 http://dx.doi.org/10.1155/2020/8979270 |
Ejemplares similares
-
Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014) -
Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury
por: CHENG, XIANG YANG, et al.
Publicado: (2016) -
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020) -
Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine
por: Sun, Meng, et al.
Publicado: (2022) -
Rhynchophylline ameliorates myocardial ischemia/reperfusion injury through the modulation of mitochondrial mechanisms to mediate myocardial apoptosis
por: Qin, Qiao-Ji, et al.
Publicado: (2019)